Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Finn

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2008
Targeting Src in breast cancerR S Finn
Minerva Gastroenterologica E Dietologica|March 16, 2012
Advanced HCC: emerging molecular therapiesR S Finn
British Journal of Cancer|January 5, 2012
Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancerR Y Tsang, R S Finn
Applied Optics|February 2, 2010
Nonlinear-optical measurement of dispersion in gasesR S Finn, J F Ward
Thorax|September 30, 2009
Iloprost-induced rashR S Finn, L Beckert, R Troughton
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 22, 2009
Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenibM Yeganeh, R S Finn, S Saab
Applied Optics|February 6, 2010
Electric-field induced harmonic generation as a probe of the focal region of a laser beamI J Bigio, R S Finn, J F Ward
Oncogene|November 12, 1998
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugsR J Pietras, M D Pegram, R S Finn, et al.
Oncogene|July 31, 1997
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cellsM D Pegram, R S Finn, K Arzoo, et al.
British Journal of Cancer|August 29, 2014
KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibitionH Hamidi, M Lu, K Chau, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2008
Targeting Src in breast cancerR S Finn
Minerva Gastroenterologica E Dietologica|March 16, 2012
Advanced HCC: emerging molecular therapiesR S Finn
British Journal of Cancer|January 5, 2012
Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancerR Y Tsang, R S Finn
Applied Optics|February 2, 2010
Nonlinear-optical measurement of dispersion in gasesR S Finn, J F Ward
Thorax|September 30, 2009
Iloprost-induced rashR S Finn, L Beckert, R Troughton
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 22, 2009
Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenibM Yeganeh, R S Finn, S Saab
Applied Optics|February 6, 2010
Electric-field induced harmonic generation as a probe of the focal region of a laser beamI J Bigio, R S Finn, J F Ward
Oncogene|November 12, 1998
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugsR J Pietras, M D Pegram, R S Finn, et al.
Oncogene|July 31, 1997
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cellsM D Pegram, R S Finn, K Arzoo, et al.
British Journal of Cancer|August 29, 2014
KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibitionH Hamidi, M Lu, K Chau, et al.
Pageof 3